Calderon MA - Search Results

1

Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy.

Nelson H, Cartier S, Allen-Ramey F, Lawton S, Calderon MA. Nelson H, et al. Among authors: calderon ma. J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):256-266.e3. doi: 10.1016/j.jaip.2014.09.018. Epub 2014 Nov 20. J Allergy Clin Immunol Pract. 2015. PMID: 25609326 Review.

2

Specific immunotherapy with high dose SO standardized grass allergen tablets was safe and well tolerated.

Calderón M, Essendrop M. Calderón M, et al. J Investig Allergol Clin Immunol. 2006;16(6):338-44. J Investig Allergol Clin Immunol. 2006. PMID: 17153880 Free article. Clinical Trial.

3

Allergen injection immunotherapy for seasonal allergic rhinitis.

Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Calderon MA, et al. Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD001936. doi: 10.1002/14651858.CD001936.pub2. Cochrane Database Syst Rev. 2007. PMID: 17253469 Free PMC article. Review.

4

Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy.

Calderon MA, Birk AO, Andersen JS, Durham SR. Calderon MA, et al. Allergy. 2007 Aug;62(8):958-61. doi: 10.1111/j.1398-9995.2007.01416.x. Allergy. 2007. PMID: 17620076 Clinical Trial.

5

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity.

Francis JN, James LK, Paraskevopoulos G, Wong C, Calderon MA, Durham SR, Till SJ. Francis JN, et al. Among authors: calderon ma. J Allergy Clin Immunol. 2008 May;121(5):1120-1125.e2. doi: 10.1016/j.jaci.2008.01.072. Epub 2008 Apr 18. J Allergy Clin Immunol. 2008. PMID: 18374405 Clinical Trial.

6

Sublingual immunotherapy for allergic Rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases.

Calderón MA, Penagos M, Durham SR. Calderón MA, et al. Clin Allergy Immunol. 2008;21:359-75. Clin Allergy Immunol. 2008. PMID: 18828517 Review. No abstract available.

7

Meta-analyses of specific immunotherapy trials.

Calderon MA. Calderon MA. Drugs Today (Barc). 2008 Dec;44 Suppl B:31-4. Drugs Today (Barc). 2008. PMID: 19221615 No abstract available.

8

Sustained effect of SQ-standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life.

Frølund L, Durham SR, Calderon M, Emminger W, Andersen JS, Rask P, Dahl R. Frølund L, et al. Allergy. 2010 Jun 1;65(6):753-7. doi: 10.1111/j.1398-9995.2009.02238.x. Epub 2009 Nov 2. Allergy. 2010. PMID: 19886920 Clinical Trial.

9

Towards evidence-based medicine in specific grass pollen immunotherapy.

Calderon M, Mösges R, Hellmich M, Demoly P. Calderon M, et al. Allergy. 2010 Apr;65(4):420-34. doi: 10.1111/j.1398-9995.2009.02292.x. Epub 2009 Dec 21. Allergy. 2010. PMID: 20028374 Review.

10

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.

Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ; Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Brozek JL, et al. J Allergy Clin Immunol. 2010 Sep;126(3):466-76. doi: 10.1016/j.jaci.2010.06.047. J Allergy Clin Immunol. 2010. PMID: 20816182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

202 results

Search Page